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Abstract
Invasive cancer causes a change in density in the affected tissue, which can be visualized by x-ray phase-contrast
tomography. However, the diagnostic value of this method has so far not been investigated in detail. Therefore, the
purpose of this study was, in a blinded manner, to investigate whether malignancy could be revealed by non-invasive x-ray
phase-contrast tomography in lymph nodes from breast cancer patients. Seventeen formalin-fixed paraffin-embedded
lymph nodes from 10 female patients (age range 37–83 years) diagnosed with invasive ductal carcinomas were analyzed by
X-ray phase-contrast tomography. Ten lymph nodes had metastatic deposits and 7 were benign. The phase-contrast images
were analyzed according to standards for conventional CT images looking for characteristics usually only visible by
pathological examinations. Histopathology was used as reference. The result of this study was that the diagnostic sensitivity
of the image analysis for detecting malignancy was 100% and the specificity was 87%. The positive predictive value was
91% for detecting malignancy and the negative predictive value was 100%. We conclude that x-ray phase-contrast imaging
can accurately detect density variations to obtain information regarding lymph node involvement previously inaccessible
with standard absorption x-ray imaging.
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Introduction
Breast cancer is the leading cause of death in cancer among
women [1]. Early diagnosis and accurate staging of the disease are
crucial for proper treatment and improved prognosis. It is of major
importance whether the cancer is confined to the breast or has
spread to the adjacent lymph nodes. The current state-of-the-art
method to investigate the regional axillary lymph nodes is the
sentinel node (SNL) technique [2]. Prior to the final surgical
intervention, a quantity of radio-labeled colloid is injected into the
breast, usually in the region around the tumor. The distribution of
the radiotracer is visualized by a gamma camera image, revealing
the lymph nodes that are draining the breast tissue with the tumor.
These local lymph nodes, usually numbering between one and
three, are called the sentinel nodes. The surgeon identifies the
sentinel node with a small Geiger probe and removes the nodes for
investigation by the pathologist. This is done either perioperatively
or following the primary operation. If the nodes show histological
metastatic deposits, an axillary dissection is performed [3].
The sensitivity and specificity of the SNL technique is generally
high. However, the technique is not feasible for all breast cancer
patients, and a non-invasive tool for identification of malignant
lymph nodes would be of particular interest for non-SNL
candidates. Suggested contra-indications for SNL are multifocal
or multicentric lesions, previous axillary surgery, previous irradi-
ation therapy, and neo-adjuvant chemotherapy [4–6], although
large investigations regarding these contraindications are still
needed.
Conventional imaging cannot accurately assess axillary lymph
node involvement. Different imaging approaches have been
evaluated for the use in axillary staging, and currently computer
tomography and ultrasonography are the most widely used.
However, no imaging modality has yet shown satisfactory
sensitivity or specificity in this respect. Factors such as size and
shape have been used to discriminate between malignant and
benign lymph nodes, but these evaluation criterions have their
obvious limitations.
A newer approach using dynamic contrast-enhanced magnetic
resonance seems promising for evaluation of primary tumors for
breast cancer patients after neo-adjuvant chemotherapy and has
been evaluated as a surrogate marker for prediction of nodal status
[7]. This indirect assessment of nodal involvement may however
be associated with an unsatisfactory high false-negative rate.
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The diagnostic value of F-18 -Fluorodeoxy-glucose-Positron
Emission Tomography (F-18-FDG-PET) with or without di-
agnostic CT has also been evaluated as a tool for preoperative
axillary staging [8,9]. But again, a sensitivity around 60–70%
seems unsatisfactory compared to SNL verified by histopatholog-
ical examination.
Due to the high prognostic implication of axillary lymph node
involvement, it is of paramount importance to identify a possible
spread of disease for proper staging and thereby choice of
treatment strategy. Especially false negative cases should be
minimized for improved prognosis but also false positive cases,
since removal of the whole axilla is associated with significant
morbidity such as lymphedema in the affected arm and limitations
of shoulder movement [10,11]. Thus, the development of a safe
pre-operative, non-invasive imaging technique to identify lymph
node metastases would be of tremendous value. Such an imaging
technique could spare the patient for axillary surgery if negative,
and if positive, the primary tumor and the affected nodes could be
removed during the same operation and proper treatment initiated
faster.
Tiny density variations in human tissue are difficult or
impossible to detect with conventional X-ray imaging, but they
can be visualized by grating-based phase-contrast X-ray tomog-
raphy [12–18]. Due to the wave-optical interaction of x-rays with
matter, the contrast available with phase-contrast imaging is much
higher than standard X-ray absorption imaging. Hence, the
density variations caused by invasive cancer can be visualized.
Here we report high-contrast biomedical phase-contrast imaging
using synchrotron radiation [19–21] applied to human lymph
nodes. The purpose of this study was, in a blinded manner, to
investigate whether malignancy could be revealed by non-invasive




Written informed consent was obtained from all participants
and the study was approved by the regional scientific ethical
committee. Seventeen formalin-fixed, paraffin-embedded axillary
lymph nodes were used for the study, all from axillary dissection
specimens from women with invasive ductal breast carcinoma. All
lymph nodes were weighed, measured on the longest diameter and
cut in half prior to formalin-fixation. One half of the formalin
fixed-paraffin-embedded lymph node was used for the study and
the other for routine histological examination.
Each sample was paraffin embedded in a small plastic tray
following the standard protocol for histology slicing. Haematoxylin
and eosin staining (H&E-staining) was performed according to
routine procedures on 10 mm sections from all samples on the
experimental half of the lymph node to verify the diagnosis. In
addition, prior to sectioning and staining, each sample was imaged
using phase-contrast tomography. For x-ray phase-contrast
imaging the paraffin embedded lymph nodes were removed from
their trays and brought to the synchrotron radiation facility.
Phase-contrast Micro-tomography
The x-ray imaging measurements were carried out at the ID19
beamline at the European Synchrotron Radiation Facility (ESRF),
in Grenoble, France [22]. A grating interferometer was placed 150
meters from the wiggler source (see Figure 1). The principle and
set-up of the x-ray grating interferometer has previously been
described in detail [12,23–27]. In this experiment we have used
a monochromatic x-ray beam at 23 keV. The Si phase grating
(G1, p-phase shifting) was placed after the sample, had period of
4.785 mm and a height of 29.5 mm and had been produced using
photolithography and wet chemical etching [27]. The Au
absorption grating (G2) was placed in front of the detector, had
period of 2.400 mm and a height of 50 mm. It had been produced
using soft X-ray lithography [28]. A FReLoN CCD detector with
an effective pixel size of 14.9614.9 mm2 with 102461024 pixels
was used. The field of view was limited horizontally by the number
of pixels of the detector, and vertically by the X-ray beam size; this
resulted in a field of 15.3 mm width and 13.7 mm height.
For each tomographic dataset four phase step projections with
an exposure time of 0.5 seconds each were collected for 701 angles
evenly distributed over 360 degrees. This resulted in a total net
exposure time of 24 minutes. Due to the large field-of-view four
samples could be measured simultaneously. The data was
reconstructed using a Hilbert-filter-based phase-contrast filtered
back-projection algorithm [29]. A phase unwrapping procedure
was applied prior to reconstruction to suppress cupping artifacts.
For each sample the dataset included (depending on the size of the
sample) 100–225 adjacent 14.9-mm-thick slices, thus providing
a full 3D image of the sample.
Data Analysis and Statistics
Each image was converted to DICOM format and imported
into the Inveon Software (Siemens Medical Solutions, Inc.,
Knoxville, TN, USA) for analysis by two experts in Medical
Imaging. The study was blinded and retrospective.
Since the technique was new and the images unlike prior
absorption x-ray images, the experts who analyzed the scans first
looked at a test set of three images and set their diagnosis, then
they were given the correct diagnosis before completing the rest of
the image analysis. This was done in order to know which features
to look for in the benign and malignant lymph nodes respectively.
The reference for metastatic disease was histopathology diagnosis
set by a pathologist who was blinded to the x-ray phase-contrast
results.
For comparison between groups for diameter and weight an
independent-samples t-test was used. The statistical analyses were
calculated using SPSS version 17.0 (SPSS Inc, Chicago, IL).
P,0.05 was considered significant.
Figure 1. Experimental setup. Not to scale. The sample is placed in
front of the interferometer as close as possible to the first grating. The
distance between the two x-ray optical transmission gratings, G1 and
G2 is dictated by the fractional Talbot order. The detector is placed
immediately after G2. The phase-contrast images are collected for each
rotation angle v by scanning G1, along the transverse direction in four
steps.
doi:10.1371/journal.pone.0054047.g001
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Results
Twenty-three samples were visualized by phase-contrast micro-
tomography. Due to technical challenges, as no experimental
protocol was available before the experiment, some samples were
excluded before the final image analysis. All samples were
embedded in paraffin but they were removed from their trays in
a way that was not optimized for the imaging procedure. For
optimal phase-contrast imaging the sample embedding should be
of convex shape and free of cracks. Establishment of this protocol
lead to failed sample handling resulting in poor image quality of 6
samples. Therefore, seventeen lymph nodes from 10 patients were
included in the final analysis. The age range of the 10 patients was
37–83 years (median age 60 years).
The 17 included lymph nodes were collected from 10 patients
with clinical suspiciousness of nodal involvement and all un-
derwent complete axillary resection. Of these 10 patients, 1 had no
metastasis in the resected axillary specimen, 3 had 1–3 affected
nodes, 3 had 4–6 affected nodes and 3 had more than 6 affected
nodes.
Of the 17 included axillary lymph nodes, histological examina-
tion confirmed that n= 10 were infiltrated with invasive ductal
breast carcinoma and n= 7 were without metastatic deposits. All
lymph nodes with metastatic deposits that were included in the
study had macro-metastases. The 10 lymph nodes with cancer
infiltration had a weight of (4.163.3) g (mean 6 standard
deviation), and a diameter of (2466.8) mm. The lymph nodes
without malignancy had a weight of (0.660.4) g, and a diameter of
Figure 2. Phase-contrast tomography images of lymph nodes. Without (upper panels) and with (lower panels) metastatic deposits from
patients diagnosed with invasive ductal breast carcinoma. The lymphoid follicles can easily be distinguished in the images of the benign lymph
nodes. In the lower panels the invasive edge (arrows) clearly mark the border between the metastatic majority (lighter) part of the lymph node and
the smaller part of the node with intact normal cells (darker).
doi:10.1371/journal.pone.0054047.g002
Imaging of Lymph Nodes by X-ray Phase-Contrast
PLOS ONE | www.plosone.org 3 January 2013 | Volume 8 | Issue 1 | e54047
(1464.3) mm. The malignant lymph nodes had a significantly
higher weight and larger diameter than the non-malignant lymph
nodes (p = 0.015 and p= 0.005, respectively).
All of the 10 metastatic lymph nodes had a longest diameter that
was above 10 mm, which is the criterion for considering the lymph
node suspicious of malignancy on CT. Two lymph nodes were
however close to 10 mm with the longest diameter of 12 and
13 mm respectively, which could be within the range of
measurement inconsistence on CT images, and the lymph nodes
could be considered non-malignant on conventional CT or not be
detected at all.
The raw data and image reconstruction was carried out by
experts in x-ray physics. The final images were analyzed by two
experts in nuclear medicine and both the physicists and the
physicians were blinded to the diagnosis of the lymph nodes. Each
of the 2 experts in Nuclear Medicine who analyzed the images had
1 false positive result and no false negative results. The false
positive sample was however different for the two experts. Thus,
the inter-observer agreement was 88% (15 of 17 lymph nodes) for
classification of the lymph nodes as malignant or benign. The
diagnostic sensitivity of the image analysis was 100% and the
specificity was 87%. The positive predictive value was 91% and
the negative predictive value was 100%. The features that were
characteristic of the benign lymph nodes, were an ordered
structure with clearly visible lymphoid follicles (see figure 2 upper
panels), whereas the malignant lymph nodes had features such as
calcification, changed morphology, and a general disorganized
appearance. From the example in figure 2 (lower panels) the
border between the cancer-infiltrated and the non-infiltrated part
of the lymph node can be seen with a clear gray level difference
(cancer infiltration lighter) due to the changed density of the tissue
caused by the cancer infiltration.
Discussion
The axillary status is one of the most important prognostic
factors for breast cancer patients. Therefore, correct assessment of
nodal involvement is of outmost importance, and the sentinel node
technique has evolved as a mandatory part in the evaluation and
staging of breast cancer patients. However, the SNL is not always
indicated, e.g. for patients undergoing neo-adjuvant chemother-
apy, and other approaches for axillary assessment are warranted.
Using x-ray phase-contrast tomography we demonstrate here
a high sensitivity (100%) as well as specificity (86%), positive
predictive value (91%) and negative predictive value (100%) with
no false-negative cases. In the non-metastatic lesions the lymphoid
follicles were clearly visible whereas the metastatic lesions had lost
this ordered morphology. This change in morphological char-
acteristics was clearly visible upon image analysis. This is the first
time that a non-invasive imaging modality has demonstrated the
ability to visually identify morphological differences between
malignant and benign lymph nodes. Accordingly, x-ray phase-
contrast micro-tomography gives histological information in a non-
invasive manner which allows for discrimination between benign
and malignant lymph nodes.
In this study, micro-metastases were not analyzed, and the
detection limit for identification of metastatic deposits in lymph
nodes is so far not known for this imaging approach. However,
given the high morphological information achievable with x-ray
phase-contrast tomography, we believe that this technique is more
powerful than imaging approaches otherwise available. In
addition, it is questionable what the prognostic implication of
micro-metastases is. It is known that intra-operative false-negative
cases are often micro-metastases or isolated tumor cells. Two
studies investigated the role of intra-operative false-negative cases.
In these studies, 75% of the false-negative cases were micro-
metastases or isolated tumor cells. There was no significant
difference in recurrence rate between patients with true-negative
SNL and patients with intra-operative false-negative SNL not
undergoing axillary lymph node dissection [30,31]. Thus, from the
results of these studies it seems possible that the clinical
significance of micro-metastases is limited.
The non-invasive diagnostic method proposed here, based upon
x-ray phase-contrast imaging, can be used for identification of
metastatic deposits in lymph nodes. Once developed into a clinical
routine this x-ray phase-contrast imaging methodology could have
a great impact on diagnosis and treatment in patients with breast
cancer. The present sentinel node technique might then be
replaced by a non-invasive preoperative x-ray phase-contrast
evaluation of lymph node involvement in patients with breast
cancer, and surgical intervention could be reduced to one
operation, and perhaps more importantly, proper choice of
treatment could be initiated faster.
The method of grating-based x-ray phase-contrast imaging has
already been demonstrated using standard laboratory x-ray
sources [16–17,32–36], making its use in the clinic feasible. We
believe that the images presented here will constitute the next step
towards a new concept for imaging cancer and possibly other
diseases. The implementation of phase-contrast x-ray imaging in
a clinical environment could be envisioned as a high-resolution
micro-CT for surgically removed tissue samples ex-vivo as an
alternative to histology, or as an in-vivo full body CT.
In conclusion, we describe a new method using phase-contrast
tomography that has a high sensitivity and specificity for non-
invasive detection of lymph node metastases. The method has
a high clinical potential and in the future may lead to non-invasive
axillary staging of breast cancer patients.
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